Trial · NCT02634684
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Prepulse Inhibition (PPI) | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine | Placebo | 22.629 | Standard Deviation 62.657 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo | Placebo | 41.162 | Standard Deviation 42.103 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Healthy Subjects: Placebo 1st, Then 10 mg Amphetamine | Placebo | 50.626 | Standard Deviation 25.850 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Healthy Subjects: 10 mg Amphetamine 1st, Then Placebo | Placebo | 50.626 | Standard Deviation 29.621 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine | Amphetamine | 32.656 | Standard Deviation 57.669 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo | Amphetamine | 39.545 | Standard Deviation 33.429 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Healthy Subjects: Placebo 1st, Then 10 mg Amphetamine | Amphetamine | 45.822 | Standard Deviation 31.777 | % inhibition of startle |
| Prepulse Inhibition (PPI) | Healthy Subjects: 10 mg Amphetamine 1st, Then Placebo | Amphetamine | 53.029 | Standard Deviation 24.671 | % inhibition of startle |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine | placebo | 31.895 | Standard Deviation 15.937 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo | placebo | 39.895 | Standard Deviation 11.704 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Healthy Subjects: Placebo 1st, Then 10 mg Amphetamine | placebo | 54.476 | Standard Deviation 11.557 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Healthy Subjects: 10 mg Amphetamine 1st, Then Placebo | placebo | 57.870 | Standard Deviation 11.153 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine | amphetamine | 33.842 | Standard Deviation 16.269 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo | amphetamine | 38.105 | Standard Deviation 12.552 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Healthy Subjects: Placebo 1st, Then 10 mg Amphetamine | amphetamine | 55.476 | Standard Deviation 11.383 | standardized T-score |
| MATRICS Consensus Cognitive Battery Performance (MCCB) | Healthy Subjects: 10 mg Amphetamine 1st, Then Placebo | amphetamine | 56.000 | Standard Deviation 11.286 | standardized T-score |
| Targeted Cognitive Training (TCT): PositScience, Inc. | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Amphetamine | placebo | -15.118 | Standard Deviation 346.088 | msec |
| Targeted Cognitive Training (TCT): PositScience, Inc. | Subjects With Schizophrenia: 10 mg Amphetamine 1st, Then Placebo | placebo | -50.158 | Standard Deviation 218.464 | msec |
| Targeted Cognitive Training (TCT): PositScience, Inc. | Healthy Subjects: Placebo 1st, Then 10 mg Amphetamine | placebo | 5.911 | Standard Deviation 75.105 | msec |
| Targeted Cognitive Training (TCT): PositScience, Inc. | Healthy Subjects: 10 mg Amphetamine 1st, Then Placebo | placebo | -2.113 | Standard Deviation 107.563 | msec |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02634684/results